We have previously shown that canine DCIS and invasive cancer resemble human DCIS and its invasive stage with respect to histopathology, expression of many tumor markers including ER, PR, HER2, and Ki-67, and their association with clinical outcomes and imaging characteristics18–20. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.